Summary:
In men with Type 2 diabetes mellitus, combined structured exercise training and broccoli sprout supplementation significantly improved apolipoprotein profiles and metabolic markers compared to exercise or supplementation alone or no intervention, though it was associated with no reported adverse effects.
| PICO | Description |
|---|---|
| Population | Forty-four adult males diagnosed with Type 2 diabetes mellitus. |
| Intervention | A 12-week combination of structured aerobic and resistance training (3 sessions/week at 60–70% 1RM/VO₂peak) plus 10 g/day of broccoli sprout supplementation taken after meals. |
| Comparison | Control group (no intervention); Training only group; Supplementation only group. |
| Outcome | The combined group exhibited the greatest improvements: ApoA-I increased (+44.92 ± 6.05 mg/dL), ApoB-100 decreased (-48.30 ± 7.20 mg/dL), ApoJ decreased (-44.05 ± 5.76 mg/dL), as well as significant reductions in glucose, insulin, and HOMA-IR. Large effect sizes suggest an additive benefit, primarily driven by exercise. |
Clinical Context
Type 2 diabetes mellitus is characterised by insulin resistance and an atherogenic lipid milieu that markedly raises cardiovascular risk. Apolipoproteins offer a more granular readout of that risk than routine lipids: ApoA-I reflects the protective HDL pathway, ApoB-100 indexes the total burden of atherogenic particles, and ApoJ (clusterin) is a stress-responsive marker linked to insulin resistance. Broccoli sprouts are a concentrated source of sulforaphane, an Nrf2-pathway activator with antioxidant and anti-inflammatory actions that has shown glucose-lowering signals in earlier work, while structured aerobic and resistance training reliably improves insulin sensitivity and lipoprotein handling. Combining the two is biologically plausible for additive metabolic benefit, and this trial addresses the gap in head-to-head apolipoprotein data.
Clinical Pearls
- Rise in protective ApoA-I: The combined arm raised ApoA-I by +44.92 ± 6.05 mg/dL, the largest gain across groups and a favourable shift in the HDL-associated pathway.
- Fall in atherogenic ApoB-100: ApoB-100 dropped by -48.30 ± 7.20 mg/dL in the combined group, indicating a substantial reduction in atherogenic particle burden.
- Lower ApoJ: ApoJ (clusterin) decreased by -44.05 ± 5.76 mg/dL, consistent with reduced metabolic stress and improved insulin sensitivity.
- Glycaemic gains, exercise-led: Significant reductions in glucose, insulin and HOMA-IR accompanied the lipoprotein changes, with large effect sizes pointing to an additive benefit that was primarily driven by exercise.
Practical Application
This protocol combines 12 weeks of supervised aerobic and resistance training three times weekly at 60–70% of 1RM/VO₂peak with 10 g/day of broccoli sprout supplement taken after meals. For men with type 2 diabetes who are able to exercise, it offers a pragmatic, food-based adjunct to pharmacotherapy and standard lifestyle advice rather than a substitute for glucose-lowering medication. Because the data suggest exercise is the dominant driver, the training component should be prioritised and the supplement viewed as a low-risk add-on. Clinicians should individualise exercise intensity, screen for cardiovascular and musculoskeletal contraindications before prescribing resistance work, and continue routine glycaemic and lipid monitoring, since benefits were measured on biomarkers over a short period.
Broader Evidence Context
Structured exercise is already a cornerstone of type 2 diabetes management, endorsed by major guidelines for its effects on glycaemia, insulin sensitivity and cardiovascular risk, and these results reinforce that role. Interest in sulforaphane from broccoli sprouts has grown after earlier small studies suggested it can modestly lower fasting glucose, though the evidence remains preliminary and heterogeneous. The trial’s emphasis on apolipoproteins also reflects a wider shift toward ApoB as a superior marker of atherogenic risk in dyslipidaemia. Overall the findings are consistent with prior work showing combined lifestyle interventions outperform single components, while adding novel apolipoprotein-level detail that complements rather than contradicts established practice.
Study Limitations
- The small sample of 44 participants limits statistical power and the precision of effect estimates.
- The cohort was exclusively adult males, so results may not generalise to women or to older patients.
- The 12-week duration cannot speak to durability or to hard cardiovascular outcomes.
- Endpoints were surrogate biomarkers (apolipoproteins, glucose, insulin, HOMA-IR) rather than clinical events.
- Supplement composition, sulforaphane content and adherence may vary, and the absence of adverse effects was observed only over the short study window.
Bottom Line
In men with type 2 diabetes, combining structured exercise with broccoli sprout supplementation produced the greatest improvements in apolipoproteins and glycaemic markers, with the benefit driven mainly by exercise and no reported harm. The combination is a sensible, low-risk adjunct to standard diabetes care, but the small single-sex sample, short follow-up and surrogate endpoints mean exercise should remain the priority and pharmacotherapy should not be displaced.
Source: Maryam Delfan, et al. “Combined Effects of Exercise and Broccoli Supplementation on Metabolic and Lipoprotein Biomarkers in Adults with Type 2 Diabetes: A Randomized Controlled Trial.” Read article here.
